We are an experienced team of
VISIONARIES,
STRATEGISTS,
and INNOVATORS
dedicated to improving patient outcomes.

About Octave 2018-07-23T20:18:48+00:00

Our Leadership Team

Octave’s team consists of highly experienced healthcare founders, high-level investors and first-in-class collaborators. 

WILLIAM HAGSTROM

CEO, Founder

Entrepreneur. Visionary. Passionate.

Bill has more than 25 years of start-up experience in a broad range of medical specialties intersecting science, technology, clinical medicine, and business strategy. Prior to founding Octave Bioscience, he served as the CEO of Crescendo Bioscience which created novel measurement tools and software in the field of rheumatology. Prior to this, he was the President of Alpha BioPartners, a strategic consulting firm advising the launch of new life sciences companies. While at Alpha BioPartners, Bill created the business plan for Crescendo and co-founded Altheus Therapeutics and Biolytx Pharmaceuticals. Prior to that, he served as the initial CEO of Selexys Pharmaceuticals and interim CEO of Inoveon in ophthalmology. In the 1990s, Bill was Chairman and CEO of UroCor, a urology specialty diagnostics company which he scaled from start-up through IPO. Earlier in his career, he was Vice President of Baxter International’s $1.0 billion Scientific Products Division and held management positions at the American Hospital Supply and Becton Dickinson. He currently serves on the board of directors for CareDx, Navican, Genalyte and CoFactor. Previously he was on the board of Prometheus Laboratories. Bill holds a BS in Business Management from Bob Jones University.

MELINDA THOMAS

COO, Co-Founder

Leader. Builder. Problem Solver.

Melinda has over two decades of experience starting and leading health companies. Using her expertise, she wraps a company around a technical/scientific team so they can focus on meeting the company’s milestones. Melinda built CardioDx, a molecular diagnostics company specializing in cardiovascular genomics, and ParAllele, a high-throughput sequencing and SNP discovery company from the foundation point. ParAllele was acquired by Affymetrix in what one investor said was their best investment of the decade. Previously, she served as the Inaugural Entrepreneur in Residence for New York City, solving problems for aspiring entrepreneurs, and as Chair of the Board for the Save the Redwoods League. Prior to ParAllele, she guided Molecular Dynamics Manufacturing, building it from an 8 person to 85 person manufacturing organization. Melinda holds an MBA from Harvard and a BS from UC Berkeley.

Our Board of Directors

WILLIAM HAGSTROM

Octave Bioscience

BROOK BYERS

Kleiner Perkins Caufield & Byers

GRANT HEIDRICH III

Independent Venture Capital & Private Equity Professional

TOM HAWES

Managing Director, Healthcare, Sandbox Industries

GEORGE SCANGOS

CEO, Vir Biotechnology

MICHAEL PELLINI

Foundation Medicine, Section 32

Our Investors

BCBS VENTURES

ECHO HEALTH VENTURES

SECTION 32

YOU WANT IMPACT.

You want to be mission driven, use the latest technologies to solve big problems, and work with passionate people. So do we!

PARTNER WITH US